These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1683917)

  • 1. Stressful life events and Graves' disease.
    Winsa B; Adami HO; Bergström R; Gamstedt A; Dahlberg PA; Adamson U; Jansson R; Karlsson A
    Lancet; 1991 Dec; 338(8781):1475-9. PubMed ID: 1683917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stressful life events and Graves' disease.
    Harris T; Creed F; Brugha TS
    Br J Psychiatry; 1992 Oct; 161():535-41. PubMed ID: 1393342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stressful life events and smoking were associated with Graves' disease in women, but not in men.
    Yoshiuchi K; Kumano H; Nomura S; Yoshimura H; Ito K; Kanaji Y; Ohashi Y; Kuboki T; Suematsu H
    Psychosom Med; 1998; 60(2):182-5. PubMed ID: 9560867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life events, daily stresses and coping in patients with Graves' disease.
    Kung AW
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):303-8. PubMed ID: 7758236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life events in the pathogenesis of Graves' disease. A controlled study.
    Sonino N; Girelli ME; Boscaro M; Fallo F; Busnardo B; Fava GA
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):293-6. PubMed ID: 8498147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stressful life events in the pathogenesis of Graves' disease.
    Radosavljević VR; Janković SM; Marinković JM
    Eur J Endocrinol; 1996 Jun; 134(6):699-701. PubMed ID: 8766938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre.
    Matos-Santos A; Nobre EL; Costa JG; Nogueira PJ; Macedo A; Galvão-Teles A; de Castro JJ
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):15-9. PubMed ID: 11453947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and risk of Graves' disease.
    Prummel MF; Wiersinga WM
    JAMA; 1993 Jan; 269(4):479-82. PubMed ID: 8419666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism.
    Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L
    Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and thyroid disorders--a meta-analysis.
    Vestergaard P
    Eur J Endocrinol; 2002 Feb; 146(2):153-61. PubMed ID: 11834423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of stressful life events on the initiation of graves' disease.
    Topcu CB; Celik O; Tasan E
    Int J Psychiatry Clin Pract; 2012 Oct; 16(4):307-11. PubMed ID: 22136213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease.
    Fukao A; Takamatsu J; Murakami Y; Sakane S; Miyauchi A; Kuma K; Hayashi S; Hanafusa T
    Clin Endocrinol (Oxf); 2003 May; 58(5):550-5. PubMed ID: 12699435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' hyperthyroidism and moderate alcohol consumption: evidence for disease prevention.
    Carlé A; Bülow Pedersen I; Knudsen N; Perrild H; Ovesen L; Rasmussen LB; Jørgensen T; Laurberg P
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):111-9. PubMed ID: 23170908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-term follow-up study of patients with non-toxic diffuse goitre in Japan.
    Hara T; Tamai H; Mukuta T; Fukata S; Kuma K; Nakagawa T
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):541-6. PubMed ID: 8252742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease, endocrine ophthalmopathy and smoking.
    Winsa B; Mandahl A; Karlsson FA
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):156-60. PubMed ID: 8451910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism.
    Holm IA; Manson JE; Michels KB; Alexander EK; Willett WC; Utiger RD
    Arch Intern Med; 2005 Jul; 165(14):1606-11. PubMed ID: 16043678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic and environmental factors in Graves disease. A review].
    Brix TH; Kyvik KO; Hegedüs L
    Ugeskr Laeger; 1998 Jan; 160(5):616-21. PubMed ID: 9470466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
    Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
    Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial morbidity of Graves' orbitopathy.
    Kahaly GJ; Petrak F; Hardt J; Pitz S; Egle UT
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):395-402. PubMed ID: 16181231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.